MétaCan
Menu
Back to cohort
Record W3160080840 · doi:10.1161/atvb.39.suppl_1.515

Abstract 515: Coronary Atheroma Regression from Serial Infusions of Autologous Selectively Delipidated Preβ-HDL-enriched Plasma on Coronary Atheroma in Patients With Homozygous Familial Hypercholesterolemia in the HALO-FH Trial

2019· article· en· W3160080840 on OpenAlexaff
Brian Ghoshhajra, Borek Foldyna, Daniel Gaudet, Étienne Khoury, Steven R. Sloan, Prediman K. Shah, Steven R. Jones, Ron Waksman, Rebecca Torguson, Ernst J. Schaefer, H. Bryan Brewer

Bibliographic record

VenueArteriosclerosis Thrombosis and Vascular Biology · 2019
Typearticle
Languageen
FieldMedicine
TopicCardiovascular Disease and Adiposity
Canadian institutionsUniversité de Montréal
Fundersnot available
KeywordsAtheromaMedicineCoronary atherosclerosisInternal medicineCardiologyFamilial hypercholesterolemiaCoronary heart diseaseCholesterol

Abstract

fetched live from OpenAlex

Background: Lipid-rich plaques are prone to rupture causing major adverse cardiac events (MACE). Selective delipidation of plasma via HDL Therapeutics PDS-2™ System converts a HDL to preβ-HDL, the most effective form of HDL for cholesterol removal from arterial plaques Objective: To determine the effect of 7 weekly serial infusions of autologous selectively delipidated preβ-HDL-enriched plasma on coronary atheroma, assessed by quantitative coronary computed tomography angiography (CCTA), in patients with homozygous familial hypercholesterolemia (HoFH). Methods: Open-label study of 6 subjects with HoFH at 3 centers. Inclusion criteria were subclinical atherosclerosis (≥20% luminal stenosis) on baseline CCTA, stable lipid-lowering therapy for ≥ 4 weeks prior, and meeting criteria for serial apheresis. All subjects received 7 weekly infusions of autologous selectively delipidated preβ-HDL-enriched plasma and baseline and final CCTA. The primary endpoint was the quantitative atheroma cross-sectional area for each plaque, and plaque composition. Plasma prior to and after each infusion was subjected to gel electrophoresis for preβ-HDL particle levels. Results: 16 coronary plaques were identified. The primary endpoint was met with a statistically significant 18% reduction in total atheroma cross-sectional area between baseline and follow-up (9.9±3.5 vs. 8.2±2.4 mm 2 ; P=0.023). This included a 20% reduction of noncalcified plaque (P=0.015), and reductions in the low-density (-38%; P=0.005) and necrotic core (-33%; P=0.007) components. The percentage of preβ-HDL particles levels increased significantly (p<0.001) by 65.92%. Conclusion: We observed coronary atheroma regression after 7 weekly serial infusions of autologous selectively delipidated preβ-HDL-enriched plasma in patients with HoFH. This was accompanied by an increase in preβ-HDL particles levels and a reduction in the low-density and necrotic core plaque portions (i.e. those associated with high-risk plaques prone to rupture and higher rates of MACE). Clinical Implications: Autologous selectively delipidated preβ-HDL-enriched plasma is the first of its kind treatment to rapidly reverse coronary atherosclerosis in patients with HoFH who are at increased risk for MACE.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.248
Teacher spread0.232 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueArteriosclerosis Thrombosis and Vascular BiologySame topicCardiovascular Disease and AdiposityFrench-language works237,207